{"cik":"0001782223","entityName":"Pyxis Oncology, Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-11-12","val":32763887,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":1077000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1927000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":1997000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":5462000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":97000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":3448000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":9000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":9000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":11000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":2450000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":572000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":307000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":29000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":12000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":3329000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":307000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":4874307,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":28418977,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":10151000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":139488000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":8103000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":134336000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AssetsFairValueDisclosure":{"label":"Assets, Fair Value Disclosure","description":"Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-09-30","val":11246000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2020-12-31","val":8080000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":133477000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2020-09-30","val":11355000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2021-09-30","val":133586000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2019-12-31","val":19721000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2019Q4I"},{"end":"2020-09-30","val":11355000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2020-12-31","val":8189000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":133586000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-8366000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":125397000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"CommonStockCapitalSharesReservedForFutureIssuance":{"label":"Common Stock, Capital Shares Reserved for Future Issuance","description":"Aggregate number of common shares reserved for future issuance.","units":{"shares":[{"end":"2021-09-30","val":28418977,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.001,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.001,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":40300000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":167000000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":2177956,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2194326,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":1289342,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1639600,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":1000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"DeferredCosts":{"label":"Deferred Costs, Noncurrent","description":"Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.","units":{"USD":[{"end":"2021-09-30","val":3501000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"DeferredOfferingCosts":{"label":"Deferred Offering Costs","description":"Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.","units":{"USD":[{"end":"2021-09-30","val":1100000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"DepreciationDepletionAndAmortization":{"label":"Depreciation, Depletion and Amortization","description":"The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":299000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":489000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"DerivativeGainLossOnDerivativeNet":{"label":"Derivative, Gain (Loss) on Derivative, Net","description":"Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":-5821000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-2560000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"DerivativeLiabilitiesCurrent":{"label":"Derivative Liability, Current","description":"Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.","units":{"USD":[{"end":"2021-09-30","val":9123000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"DerivativeLiabilitiesNoncurrent":{"label":"Derivative Liability, Noncurrent","description":"Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.","units":{"USD":[{"end":"2021-09-30","val":67000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":-8.43,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-2.93,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-40.27,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-8.96,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"EffectiveIncomeTaxRateContinuingOperations":{"label":"Effective Income Tax Rate Reconciliation, Percent","description":"Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"pure":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":{"label":"Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount","description":"Amount of cost to be recognized for option under share-based payment arrangement.","units":{"USD":[{"end":"2021-09-30","val":10800000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"FederalIncomeTaxExpenseBenefitContinuingOperations":{"label":"Federal Income Tax Expense (Benefit), Continuing Operations","description":"Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":2406000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":767000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":9463000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":3772000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"IncomeLossFromEquityMethodInvestments":{"label":"Income (Loss) from Equity Method Investments","description":"Amount of income (loss) for proportionate share of equity method investee's income (loss).","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":-231000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInAccountsPayable":{"label":"Increase (Decrease) in Accounts Payable","description":"The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":117000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":610000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities","description":"Amount of increase (decrease) in accrued expenses, and obligations classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":960000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":3164000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInDerivativeLiabilities":{"label":"Increase (Decrease) in Derivative Liabilities","description":"The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":3369000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInOperatingLeaseLiability":{"label":null,"description":null,"units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-278000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":-455000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":84000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":836000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"InvestmentIncomeInterest":{"label":"Investment Income, Interest","description":"Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":66000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":1000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":16000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":6000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"LesseeOperatingLeaseLiabilityPaymentsDue":{"label":"Lessee, Operating Lease, Liability, to be Paid","description":"Amount of lessee's undiscounted obligation for lease payment for operating lease.","units":{"USD":[{"end":"2021-09-29","val":33800000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"end":"2021-09-30","val":300000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":3854000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":16904000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":10151000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":139488000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":3689000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":16837000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"LiabilitiesFairValueDisclosure":{"label":"Financial and Nonfinancial Liabilities, Fair Value Disclosure","description":"Fair value of financial and nonfinancial obligations.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":34000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":149144000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-1483000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":-590000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-6917000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":-23157000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-1958000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":-3100000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":-8249000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-3191000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":-36968000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":-8003000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-59146000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-14175000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"NonoperatingIncomeExpense":{"label":"Nonoperating Income (Expense)","description":"The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":66000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":1000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-5624000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-2554000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":8315000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":3192000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":53291000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":11621000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-8315000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-3192000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-53291000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-11621000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OperatingLeaseExpense":{"label":"Operating Lease, Expense","description":"Amount of operating lease expense. Excludes sublease income.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":289000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":448000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"OperatingLeaseLiabilityCurrent":{"label":"Operating Lease, Liability, Current","description":"Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.","units":{"USD":[{"end":"2020-12-31","val":615000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":325000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"OperatingLeaseLiabilityNoncurrent":{"label":"Operating Lease, Liability, Noncurrent","description":"Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.","units":{"USD":[{"end":"2020-12-31","val":165000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"}]}},"OperatingLeaseRightOfUseAsset":{"label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","units":{"USD":[{"end":"2020-12-31","val":836000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":388000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"OperatingLeasesRentExpenseNet":{"label":"Operating Leases, Rent Expense, Net","description":"Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":500000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":200000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":500000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":200000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OtherAssetsNoncurrent":{"label":"Other Assets, Noncurrent","description":"Amount of noncurrent assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":109000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":109000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PaymentsOfStockIssuanceCosts":{"label":"Payments of Stock Issuance Costs","description":"The cash outflow for cost incurred directly with the issuance of an equity security.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":2451000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"PaymentsToAcquireInterestInJointVenture":{"label":"Payments to Acquire Interest in Joint Venture","description":"The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":50000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"PaymentsToAcquirePropertyPlantAndEquipment":{"label":"Payments to Acquire Property, Plant, and Equipment","description":"The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1483000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":540000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"PrepaidExpenseCurrent":{"label":"Prepaid Expense, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":23000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":859000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":3000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ProceedsFromIssuanceOfConvertiblePreferredStock":{"label":"Proceeds from Issuance of Convertible Preferred Stock","description":"The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":151581000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ProceedsFromStockOptionsExercised":{"label":"Proceeds from Stock Options Exercised","description":"Amount of cash inflow from exercise of option under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":31000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":14000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-8249000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":-59146000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"PropertyPlantAndEquipmentNet":{"label":"Property, Plant and Equipment, Net","description":"Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":1103000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1154000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":5909000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":2425000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":43828000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":7849000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ResearchAndDevelopmentInProcess":{"label":"Research and Development in Process","description":"The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":20000000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"RestrictedCash":{"label":"Restricted Cash","description":"Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.","units":{"USD":[{"end":"2020-09-30","val":109000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2021-09-30","val":109000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings":{"label":"Restricted Stock, Shares Issued Net of Shares for Tax Withholdings","description":"Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.","units":{"shares":[{"start":"2019-01-01","end":"2019-12-31","val":994650,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2019"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-15743000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":-74889000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability":{"label":"Right-of-Use Asset Obtained in Exchange for Operating Lease Liability","description":"Amount of increase in right-of-use asset obtained in exchange for operating lease liability.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1186000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":29000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":3329000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number","description":"The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.","units":{"shares":[{"end":"2020-12-31","val":888612,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":554724,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period","description":"The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":333888,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate","description":"The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.","units":{"pure":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum","description":"The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.","units":{"pure":[{"start":"2020-01-01","end":"2020-09-30","val":0.874,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0.874,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0.7517,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":0.7313,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum","description":"The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.","units":{"pure":[{"start":"2020-01-01","end":"2020-09-30","val":0.828,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0.874,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0.7288,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":0.7288,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum","description":"The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.","units":{"pure":[{"start":"2020-01-01","end":"2020-09-30","val":0.0056,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0.0038,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0.0116,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":0.0096,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum","description":"The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.","units":{"pure":[{"start":"2020-01-01","end":"2020-09-30","val":0.0038,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0.0038,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0.0081,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":0.0081,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2021-09-30","val":927403,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price","description":"The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.","units":{"USD/shares":[{"end":"2021-09-30","val":4.89,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period","description":"The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":345658,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":3672351,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":0.04,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0.04,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":4.15,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":5.59,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value","description":"Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.","units":{"USD":[{"end":"2020-12-31","val":348000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":34755000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":220383,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":3530706,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2020-12-31","val":0.64,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":6.16,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price","description":"Weighted average price at which option holders acquired shares when converting their stock options into shares.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-09-30","val":0.88,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price","description":"Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-09-30","val":5.29,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-09-30","val":6.38,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value","description":"Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.","units":{"USD":[{"end":"2021-09-30","val":10304000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations":{"label":"State and Local Income Tax Expense (Benefit), Continuing Operations","description":"Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":-2874000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-4822000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q1I"},{"end":"2020-06-30","val":-7910000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2I"},{"end":"2020-09-30","val":-11087000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-15645000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-50160000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q1I"},{"end":"2021-06-30","val":-57588000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2I"},{"end":"2021-09-30","val":-71439000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"StockIssuedDuringPeriodSharesStockOptionsExercised":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period","description":"Number of share options (or share units) exercised during the current period.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":16370,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2020-04-01","end":"2020-06-30","val":2000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2"}]}},"StockIssuedDuringPeriodValueRestrictedStockAwardGross":{"label":"Stock Issued During Period, Value, Restricted Stock Award, Gross","description":"Aggregate value of stock related to Restricted Stock Awards issued during the period.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":1000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":3000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":3000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":3000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":3000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"StockIssuedDuringPeriodValueStockOptionsExercised":{"label":"Stock Issued During Period, Value, Stock Options Exercised","description":"Value of stock issued as a result of the exercise of stock options.","units":{"USD":[{"start":"2021-07-01","end":"2021-09-30","val":14000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"UnrealizedGainLossOnDerivatives":{"label":"Unrealized Gain (Loss) on Derivatives","description":"The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":-5821000,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":979081,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":1088222,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":1468777,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":1581610,"accn":"0000950170-21-004476","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}}}}}